Named on one round in the feed.
Individual investorSince 2024-10-09
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Basecamp Research A London AI company that trains frontier models on its proprietary Trillion Gene Atlas to design therapeutics, starting with in vivo cell therapies | Series B Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $60M | 2024-10-09 | [ PART ] |